Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS)

Ilaria Dicembrini^a, Valentina Vitale^b, Claudia Cosentino^b, Barbara Cresci^b, Laura Pala^b, Maria Pieri^b, Dimitri Yannas^a, Matteo Vannucci^a, Elena Zago^a, Alessia Romani^a, Chiara Delli Poggi^a, S Mariani^a, Daniele Scoccimarro^a, Carlotta Cocchetti^a, Matteo Monami^b, Edoardo Mannucci^{c d}✉

1. ^aDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, viale Morgagni 50, Florence, Italy
2. ^bDiabetes Unit, Careggi Hospital, Largo Brambilla 3, 50127, Florence, Italy
3. ^cDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, viale Morgagni 50, Florence, Italy. edoardo.mannucci@unifi.it
4. ^dDiabetes Unit, Careggi Hospital, Largo Brambilla 3, 50127, Florence, Italy. edoardo.mannucci@unifi.it
5. ✉Corresponding author